Valuation : Incyte Corporation

Market Cap 25.54B 21.97B 20.73B 18.88B 35.3B 2,442B 35.62B 247B 95B 1,239B 95.92B 93.82B 3,934B P/E 2026 *
56.2x
P/E 2027 * 17.4x
Enterprise Value 21.31B 18.33B 17.29B 15.75B 29.45B 2,038B 29.72B 206B 79.27B 1,034B 80.03B 78.28B 3,283B EV / Sales 2026 *
3.59x
EV / Sales 2027 * 3.12x
Free-Float
98.16%
Yield 2026 *
-
Yield 2027 * -
1 day-2.44%
1 week-4.05%
Current month-0.33%
1 month+1.04%
3 months+16.53%
6 months+27.91%
Current year+24.34%
1 week 122.22
Extreme 122.222
128.08
1 month 117.56
Extreme 117.56
130.8
Current year 89.25
Extreme 89.25
132.6
1 year 81.09
Extreme 81.09
132.6
3 years 50.27
Extreme 50.27
132.6
5 years 50.27
Extreme 50.27
132.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 2025-06-25
Director of Finance/CFO 57 2026-05-03
President 62 2023-06-04
Director TitleAgeSince
Chairman 59 2025-06-25
Director/Board Member 72 2015-01-19
Director/Board Member 64 2015-01-19
Date Insider Type Main position Quantity % Market Cap. Importance
8/25/26 Tax

EVP, Human Resources

-504 0.0002%
8/19/26 Sell

Chairperson

-10,801 0.0053%
8/12/26 Sell

Chairperson

-10,803 0.0053%
Change 5-day change 1-year change 3-year change Capi.($)
-2.44%-4.05%+42.39%+90.68% 25.54B
-1.60%-5.56%+43.31%-4.44% 80.65B
-1.00%-2.50%-19.26%-37.42% 59.12B
+0.08%-8.87%+458.08%+28.23% 54.14B
-2.00%-5.20%-11.09%+27.83% 50.1B
-1.42%-8.61%-3.21%+144.72% 45.33B
+2.25%-3.96%+51.20%-16.72% 31.14B
-3.92%-7.32%-6.49%+166.90% 21.8B
-0.99%-4.61%+62.88%+97.84% 16.06B
-4.04%-2.82%+38.38%+156.87% 14.87B
Average -1.52%-3.46%+65.62%+65.45% 39.88B
Weighted average by Cap. -1.28%-3.72%+76.66%+40.76%

Financials

2026 *2027 *
Net sales 5.94B 5.11B 4.82B 4.39B 8.21B 568B 8.29B 57.42B 22.1B 288B 22.31B 21.83B 915B 6.27B 5.39B 5.08B 4.63B 8.66B 599B 8.74B 60.54B 23.3B 304B 23.53B 23.01B 965B
Net income 466M 401M 378M 344M 644M 44.54B 650M 4.5B 1.73B 22.59B 1.75B 1.71B 71.75B 1.5B 1.29B 1.21B 1.11B 2.07B 143B 2.09B 14.46B 5.56B 72.54B 5.62B 5.49B 230B
Net Debt -4.23B -3.64B -3.43B -3.13B -5.84B -404B -5.9B -40.87B -15.73B -205B -15.88B -15.54B -651B -5.99B -5.15B -4.86B -4.43B -8.28B -573B -8.35B -57.89B -22.28B -291B -22.5B -22.01B -923B
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
26-09-10 US$122.85 -2.51% 823,097
26-09-09 US$126.01 +1.29% 1,301,228
26-09-08 US$124.40 -1.85% 1,283,253
26-09-04 US$126.75 -0.98% 1,036,073
26-09-03 US$128.00 -0.64% 910,226
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
126.01USD
Average target price
127.74USD
Spread / Average Target
+1.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!